Cardiol Therapeutics Inc. (CRDL) Net Income by Year
Cardiol Therapeutics Inc. reported a net loss of $24.7M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Cardiol Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CRDL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CRDL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Cardiol Therapeutics Inc. financials
Frequently Asked Questions
What was Cardiol Therapeutics Inc.'s net income in fiscal year 2025?
Cardiol Therapeutics Inc. reported a net loss of $24.7M in fiscal year 2025.
How fast is Cardiol Therapeutics Inc.'s net income growing?
Cardiol Therapeutics Inc. (CRDL) reported a $25.5M net loss in fiscal year 2024 and a $24.7M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Cardiol Therapeutics Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Cardiol Therapeutics Inc. (CRDL) net income went from -$16.2M in fiscal year 2020 to -$24.7M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Cardiol Therapeutics Inc. (CRDL) reported on that line in every period on record.